Andjelkovic M., Camp, J. V., Meulenaer, D. B., Depaemelaere, G., Socaciu, C., Verloo, M., and Verhe, R. (2006). Iron-chelation properties of phenolic acids bearing catechol and galloyl groups. Food chemistry. 98, 23-31
Barros, J., Serrani-Yarce, J. C., Chen, F., Baxter, D., Venables, B. J. and Dixon, R. A. (2016) “Role of bifunctional ammonia-lyase in grass cell wall biosynthesis”. Nature Plants. 2: 16050.
Beard, J. L. (2001) “Iron biology in immune function, muscle metabolism and neuronal functioning”. Journal of Nutrition. 131(2): 5685-5805
Blache, D., Durand, P., Prost, M., and Loreau, N. (2002). (+)-Catechin inhibits platelet hyperactivity induced by an acute iron load in vivo. Free Radical Biology and Medicine, 33, 1670–1680
Brown, J. E., Khodr, H., Hider, R. C., and Rice-Evans, C. A. (1998). Structural dependence of flavonoid interactions with Cu2+ ions: implications for their antioxidant properties. Biochemical Journal, 330, 1173–1178
Cabantchik, Z. I., (1995) Iron Chelators as antimalarials: the biochemical basis of selective cytotoxicity. Parasitology Today 11, 74-78
Cuvelier, M-E., Richard, H. and Berset, C. (1991) “Comparison of the antioxidative activity of some acid-phenols: structure-activity relationship”. Bioscience, Biotechnology and Biochemistry. 56(2): 324-325
Danilewicz, J. C. (2003). Review of reaction mechanisms of oxygen and proposed intermediate reduction products in wine: central role of iron and copper. American Journal of Enology and Viticulture, 54, 73–85
Elhabiri, M., Carrer, C., Marmolle, F., and Traboulsi, H. (2006). Complexation of iron (III) by catecholate-type polyphenols. Inorganica Chimica Acta, 360, 353–359.
Golenser, J., Tsafack, A., Amichai, Y., Libman, J., Shanzer, A. and Cabantchik, Z. (1995). Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores. Antimicrobial Agents and Chemotherapy, 39(1), pp.61-65.
Gordeuk, V. R., Brittenham G. and Thuma P. E. (1994). Iron chelation as a chemotherapeutic strategy: In the treatment of malaria. Bergeron and G. M. Brittenham (ed.).The development of iron chelators for clinical use. CRC Press, Boca, Fla, p 11-130
Haslam, E. (1996). Natural polyphenols (vegetable tannins) as drugs: Possible modes of action. Journal of Natural Products, 59, 205–215
Heppner, D. G., Hallaway P. E., Kontoghiorghes G. J., and Eaton J. W. (1988). Antimalarial properties of orally active iron chelators. Blood 72: 357-361
Johnson J.D, Dennull R.A, Gerena L, Lopez-Sanchez M, Roncal N.E, Waters N.C.(2007) Assessment and continued validation of the malaria SYBR green I-based fluorescence assay for use in malaria drug screening. Antimicrob Agents Chemother. 2007 Jun;51(6):1926-33. Epub 2007 Mar 19.
Khokhar, S., & Apenten, R. K. O. (2003). Iron binding characteristics of phenolic compounds: some tentative structure–activity relations. Food Chemistry, 81, 133–140.
Kim, E. O., Min, K. J., Kwon, T. K., Um, B. H., Moreau, R. A., Choi, S. W. (2012) Antiinflammatory activity of hydroxycinnamic acid derivatives isolated from corn bran in lipopolysaccharide-stimulated Raw 264.7 macrophages. Food Chem Toxicol.50 (5):1309–16.
Kono, Y., Kashine, S., Yoneyama, T., Sakamoto, Y., Matsui, Y., Shibata, H. (1998) Iron Chelation by Chlorogenic Acid as a Natural Antioxidant. Bioscience, Biotechnology, and Biochemistry, 62:1, 22-2
Moran, J. F., Klucas, R. V., Grayer, R. J., Abian, J., & Becana, M. (1997). Complexes of iron with phenolic compounds from soybean nodules and other legume tissues: prooxidant and antioxidant properties. Free Radical Biology and Medicine, 22, 861–870.
Olliaro, P. and Wirth, D. (1997). New Targets for Antimalarial Drug Discovery. Journal of Pharmacy and Pharmacology, 49(S2), pp.29-33
Pradines, B. (2002). Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum. Journal of Antimicrobial Chemotherapy, 50(2), pp.177-187.
Quashie, N.B., Duah, N.O., Abuaku, B, Quaye L., Ayanful-Torgby, R., Akwoviah, G.A., Kweku, M., Johnson, J.D., Lucchi, N.W., Udhayakumar, V., Duplessis, C., Kronmann, K.C., Koram, K.A., (2013). A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs. Malar J. 12:450.
Reinke, L. A., Moore, D. R., Rau, J. M., & Mccay, P. B. (1995). Inorganic-phosphate promotes redox cycling of iron in livermicrosomes – effects on free-radical reactions. Archives of Biochemistry and Biophysics, 316, 758–764.
Rice-Evans, C. A., Miller, N. J., & Paganga, G. (1996). Structureantioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biology and Medicine, 20, 933–956.
Snow, R.W., C.A. Guerra, A.M. Noor, H.Y. Myint, and S.I. Hay. 2005. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 434:214–217
Sroka, Z., & Cisowski, W. (2003). Hydrogen peroxide scavenging, antioxidant and anti-radical activity of some phenolic acids. Food and Chemical Toxicology, 41, 753–758
Welch, K. D., Davis, T. Z., and Aust, S. D. (2002). Iron autoxidation and free radical generation: effects of buffers, ligands, and chelators. Archives of Biochemistry and Biophysics, 397, 360– 369.
WHO (2016) World Malaria Report 2016. Geneva, Switzerland: World Health Organization Wijesundera Mde S (1988) Malaria outbreaks in new foci in Sri Lanka. Parasitol Today 4: 147– 150